HARADA, T., SAITO, H., KARINO, F., ISAKA, T., MURAKAMI, S., KONDO, T., . . . YAMADA, K. (2014). Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy. D.A. Spandidos.
Chicago Style CitationHARADA, TAISHI, HARUHIRO SAITO, FUMI KARINO, TETSUYA ISAKA, SHUJI MURAKAMI, TETSURO KONDO, FUMIHIRO OSHITA, YOHEI MIYAGI, i KOUZO YAMADA. Clinical Usefulness of Testing for UDP Glucuronosyltransferase 1 Family, Polypeptide A1 Polymorphism Prior to the Inititation of Irinotecan-based Chemotherapy. D.A. Spandidos, 2014.
Cita MLAHARADA, TAISHI, et al. Clinical Usefulness of Testing for UDP Glucuronosyltransferase 1 Family, Polypeptide A1 Polymorphism Prior to the Inititation of Irinotecan-based Chemotherapy. D.A. Spandidos, 2014.